FTC Policy Change May Signal Increased Scrutiny For “Anticompetitive” Health Care Transactions

On October 25, 2021, the Federal Trade Commission (FTC) published a policy statement that reinstated its “prior approval” policy applicable to parties subject to an FTC order that are contemplating a future merger, acquisition or other applicable transaction. As explained in the FTC’s press release, the “prior approval” policy was previously suspended in a 1995 FTC policy statement, which policy statement has now been rescinded. In summary, organizations subject to a consent order or other FTC order […]

By | November 20th, 2021 ||

Alston & Bird Health Care Week In Review, November 12, 2021

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies, and analyses; and other health policy news.

This week, HHS announced new investments to remove barriers for eligible adults and children to access COVID-19 rapid diagnostic tests and vaccines. Read more about these actions and other news below.

I. Regulations, Notices & Guidance

On […]

By | November 16th, 2021 ||

Healthcare Partner Christopher Anderson Joins Arnold & Porter’s Corporate & Finance Practice In Chicago

CHICAGO, November 1, 2021 – Arnold & Porter announced today that Christopher Anderson has joined the firm’s Corporate & Finance practice as a partner, resident in Chicago.

Derek Stoldt, co-chair of the firm’s Corporate & Finance practice, said: “Chris is a highly regarded lawyer with unique experience in complex healthcare transactions. His expertise in navigating matters involving healthcare providers, digital health, telemedicine, artificial intelligence, and healthcare software products will be greatly beneficial to our clients. More […]

By | November 5th, 2021 ||